In Chinese Han tuberculosis patients who received anti-tuberculosis treatment, with NR1I2 rs7643645 (A > G) were associated with increased risk of anti-tuberculosis drug-induced hepatotoxicity (ATDH) (GG genotype), while carriers of the NR1I2 rs2276707 (C > T) were linked with reduced risk of ATDH [75]. This evidence concerns the gene NR1I2 and tuberculosis.